Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas
Meagan B. Myers, Malathi Banda, Karen L. McKim, et al.
Neoplasia (2016) Vol. 18, Iss. 4, pp. 253-263
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
Letícia Martins Guimarães, Bruna Pizziolo Coura, Ricardo Santiago Gomez, et al.
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 45
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants
Stephanie Schubert, Jana Lisa van Luttikhuizen, Bernd Auber, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 11, pp. 2683-2694
Open Access | Times Cited: 50
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Julie Gottlieb Fisher, David L. Tait, Elizabeth Garrett‐Mayer, et al.
Targeted Oncology (2020) Vol. 15, Iss. 6, pp. 733-741
Closed Access | Times Cited: 39
Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
Bei Li, Rongxin Geng, Qi Wu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 32
Metabolic Signatures of Tumor Responses to Doxorubicin Elucidated by Metabolic Profiling in Ovo
Iman W. Achkar, Sara Abdul Kader, Shaima S. Dib, et al.
Metabolites (2020) Vol. 10, Iss. 7, pp. 268-268
Open Access | Times Cited: 23
miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma
Yan Wang, Daoquan Dong, Shuqi Jiang, et al.
Cellular Physiology and Biochemistry (2018) Vol. 49, Iss. 5, pp. 1755-1765
Open Access | Times Cited: 23
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
Weixin Yan, Aiguo Zhang, Michael J. Powell
Chinese Journal of Cancer (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 21
Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes
Constanze Elfgen, Kelly Reeve, Linda Moskovszky, et al.
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 8, pp. 2051-2059
Closed Access | Times Cited: 20
The Association of IL-1 and HRAS Gene Polymorphisms with Breast Cancer Susceptibility in a Jordanian Population of Arab Descent: A Genotype–Phenotype Study
Laith N. AL‐Eitan, Bashar H. Al-Ahmad, Fouad Al‐Momani
Cancers (2020) Vol. 12, Iss. 2, pp. 283-283
Open Access | Times Cited: 18
Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids
Malathi Banda, Karen L. McKim, Meagan B. Myers, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0238862-e0238862
Open Access | Times Cited: 18
Development of a hybridization chain reaction-powered lab-on-fiber device for ultrafast point-of-care testing of circulating tuor DNA in whole blood
Jiaxin Xu, Xiangzhi Han, Wenjuan Xu, et al.
Talanta (2023) Vol. 259, pp. 124475-124475
Closed Access | Times Cited: 6
Variation in organ-specificPIK3CAandKRASmutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas
Barbara L. Parsons, Karen L. McKim, Meagan B. Myers
Environmental and Molecular Mutagenesis (2017) Vol. 58, Iss. 7, pp. 466-476
Open Access | Times Cited: 19
Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients
Auhood Nassar, Mohamed Abouelhoda, Osman Mansour, et al.
Journal of Advanced Research (2020) Vol. 24, pp. 149-157
Open Access | Times Cited: 17
Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity
Paula S. Ginter, Patrick J. McIntire, Boaz Kurtis, et al.
Modern Pathology (2020) Vol. 33, Iss. 9, pp. 1764-1772
Open Access | Times Cited: 17
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy
Montserrat Estruch, Kristian Reckzeh, Camilla Vittori, et al.
Leukemia (2020) Vol. 35, Iss. 7, pp. 2030-2042
Closed Access | Times Cited: 17
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS
Metehan Ilter, Ramazan Kaşmer, Farzaneh Jalalypour, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 10
Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk
Kelly L. Harris, Meagan B. Myers, Karen L. McKim, et al.
Environmental and Molecular Mutagenesis (2019) Vol. 61, Iss. 1, pp. 152-175
Open Access | Times Cited: 17
Combined Detection of HER2, Ki67, and GSTP1 Genes on the Diagnosis and Prognosis of Breast Cancer
Bo Song, Lu Wang, Yang Zhang, et al.
Cancer Biotherapy and Radiopharmaceuticals (2018) Vol. 34, Iss. 2, pp. 85-90
Open Access | Times Cited: 16
Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study
Mauro Scimia, Jinwei Du, Francesco Pepe, et al.
Journal of Clinical Pathology (2018) Vol. 71, Iss. 12, pp. 1123-1126
Closed Access | Times Cited: 15
CarcSeq detection of lorcaserin-induced clonal expansion of Pik3ca H1047R mutants in rat mammary tissue
Jennifer Faske, Meagan B. Myers, Matthew S. Bryant, et al.
Toxicological Sciences (2024) Vol. 201, Iss. 1, pp. 129-144
Open Access | Times Cited: 1
Quantification of cancer driver mutations in human breast and lung DNA using targeted, error‐corrected CarcSeq
Kelly L. Harris, Vijay Walia, Binsheng Gong, et al.
Environmental and Molecular Mutagenesis (2020) Vol. 61, Iss. 9, pp. 872-889
Open Access | Times Cited: 11
Comprehensive characteristics of somatic mutations in the normal tissues of patients with cancer and existence of somatic mutant clones linked to cancer development
Ji‐Hye Oh, Chang Ohk Sung
Journal of Medical Genetics (2020) Vol. 58, Iss. 7, pp. 433-441
Closed Access | Times Cited: 9
A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening
Qing Sun, Larry Pastor, Jinwei Du, et al.
PLoS ONE (2021) Vol. 16, Iss. 10, pp. e0244332-e0244332
Open Access | Times Cited: 9
Modern conception of carcinogenesis creates opportunities to advance cancer risk assessment
Barbara L. Parsons
Current Opinion in Toxicology (2018) Vol. 11-12, pp. 1-9
Open Access | Times Cited: 9
Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics
Santiago Ramón y Cajal, Stefan Hümmer, Vicente Peg, et al.
Histopathology (2019) Vol. 75, Iss. 1, pp. 4-19
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top